Primary Site >> Colorectal Cancer
Gene >> FOXC2
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
Ref: Gene expression of mesenchyme forkhead 1 (FOXC2) significantly correlates with the degree of lymph node metastasis in colorectal cancer. PMID: 22216698 |
Ref: Epithelial-to-mesenchymal and mesenchymal-to-epithelial transitions in the colon. PMID: 22363130 |
Ref: Isolation and characterization of calcium sensing receptor null cells: a highly malignant and drug resistant phenotype of colon cancer. PMID: 23055106 |
Ref: Evaluation of cancer stem cell markers CD133, CD44, CD24: association with AKT isoforms and radiation resistance in colon cancer cells. PMID: 24760019 Ref: Elevated HOXB9 expression promotes differentiation and predicts a favourable outcome in colon adenocarcinoma patients. PMID: 25025961 Ref: FOXC2 promotes colorectal cancer proliferation through inhibition of FOXO3a and activation of MAPK and AKT signaling pathways. PMID: 25069037 |
Ref: FOXC2 promotes colorectal cancer metastasis by directly targeting MET. PMID: 25381815 Ref: Overexpression of forkhead Box C2 promotes tumor metastasis and indicates poor prognosis in colon cancer via regulating epithelial-mesenchymal transition. PMID: 26269761 |
Ref: Downregulation of Foxc2 enhances apoptosis induced by 5-fluorouracil through activation of MAPK and AKT pathways in colorectal cancer. PMID: 26893778 |
Ref: Genistein induces apoptosis of colon cancer cells by reversal of epithelial-to-mesenchymal via a Notch1/NF-kappaB/slug/E-cadherin pathway. PMID: 29202800 |
Ref: NFATC3-PLA2G15 Fusion Transcript Identified by RNA Sequencing Promotes Tumor Invasion and Proliferation in Colorectal Cancer Cell Lines. PMID: 29909608 |